How long does targeted therapy take to work for chronic myeloid leukaemia?

A complete blood count can show early changes, such as improvement in abnormal cell levels or recovery of other blood cells. Molecular testing looks more closely for the leukaemia marker linked with the condition and may take longer to show the full effect. Results are compared over repeated visits. The medicine, dose, adherence, interactions and disease phase can all influence the pattern, so a slower result does not automatically mean the treatment is unsuitable.

Take the tablet at the prescribed time and ask the team what to do if you vomit or miss a dose. Mention antacids, supplements and other medicines before using them. Keep appointments for blood counts and molecular tests, and report swelling, muscle cramps, rash, stomach symptoms or unusual tiredness. Consistent dosing helps the team interpret whether the medicine is controlling the leukaemia.

Seek urgent advice for fever, unexplained bleeding, severe breathlessness, chest pain, fainting, sudden swelling or a severe rash. These symptoms can have causes unrelated to response, but may need assessment for infection, blood-cell changes or medicine effects.

Ask which blood and molecular results are expected first, when each test will be repeated, how missed doses affect interpretation, and what findings would prompt a dose change or different medicine.